Why the study?
Does aspirin compared with warfarin reduce the incidence of thromboembolism in patients after Fontan procedure?
Does aspirin compared with warfarin reduce the incidence of thromboembolism in patients after Fontan procedure?
Aspirin and warfarin are both effective for thromboprophylaxis after the Fontan procedure, with no significant difference in efficacy between the two agents.
Either aspirin or warfarin suffices for post-Fontan thromboprophylaxis; reinforces guideline consensus on equivalent efficacy.
This study shows a significantly lower incidence of TE after Fontan procedure if either aspirin or warfarin is used. This meta-analysis suggests no significant difference in incidence of early or late TE in patients receiving aspirin compared with warfarin.
No takes yet. Share an insight, caveat, or question.
Alsaied et al. (2015) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: